Similar articles

• [Changes in the indication of surgical treatment for pulmonary tuberculosis in accordance with the introduction of rifampicin based on bacteriological findings on culture of resected specimens (author's transl)].

  [No authors listed] [No authors listed] Kekkaku. 1977 Jul;52(7):353-60. Kekkaku. 1977. PMID: 409871 Japanese. No abstract available.
• [Bacteriological relapse among the previously treated advanced pulmonary tuberculosis patients whose sputum converted to negative by the rifampicin treatment, with special reference to the duration of rifampicin administration (author's transl)].

  Yamamoto M, Morishita M, Hirano Y, Nagata A, Yazaki M. Yamamoto M, et al. Kekkaku. 1974 Jul;49(7):195-9. Kekkaku. 1974. PMID: 4214961 Japanese. No abstract available.
• [A long-term observation on previously treated cases of pulmonary tuberculosis retreated with rifampicin for more than six months (author's transl)].

  Tamura M, Takazawa N, Asada T, Ikegaki H, Yamada M, Kushiro S, Tada T. Tamura M, et al. Kekkaku. 1979 May;54(5):285-95. Kekkaku. 1979. PMID: 113607 Japanese. No abstract available.
• [Pulmonopathy (including tuberculosis)--mycobacteriosis (including tuberculosis) (author's transl)].

  Freerksen E. Freerksen E. Offentl Gesundheitswes. 1979 Oct;41(10):698-706. Offentl Gesundheitswes. 1979. PMID: 161371 Review. German. No abstract available.
• [Significance of the L transformation and reversion of the causative agent in the epidemiology of tuberculosis].

  Khomenko AG, Kochemasova ZN, Dykhno MM, Zemskova ZS, Dorozhkova IR. Khomenko AG, et al. Zh Mikrobiol Epidemiol Immunobiol. 1984 Mar;(3):9-14. Zh Mikrobiol Epidemiol Immunobiol. 1984. PMID: 6428092 Review. Russian. No abstract available.